Christopher Rhodes to Endothelial Cells
This is a "connection" page, showing publications Christopher Rhodes has written about Endothelial Cells.
Connection Strength
0.467
-
Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nat Commun. 2024 Jan 06; 15(1):330.
Score: 0.179
-
Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 2009 Jan; 121(1):69-88.
Score: 0.062
-
Ferroptosis-Mediated Inflammation Promotes Pulmonary Hypertension. Circ Res. 2024 Nov 08; 135(11):1067-1083.
Score: 0.047
-
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation. 2023 05 23; 147(21):1606-1621.
Score: 0.042
-
PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension. Cells. 2023 01 14; 12(2).
Score: 0.042
-
Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency. Chest. 2021 10; 160(4):1442-1458.
Score: 0.037
-
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension. Nat Commun. 2020 03 04; 11(1):1185.
Score: 0.034
-
miR-21/DDAH1 pathway regulates pulmonary vascular responses to hypoxia. Biochem J. 2014 Aug 15; 462(1):103-12.
Score: 0.023